Clinical Trials Directory

Trials / Completed

CompletedNCT00662142

Effect of 8-Week Dietary DHA Supplementation on Cerebral Blood Flow and Metabolic Function

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Cincinnati · Academic / Other
Sex
Male
Age
8 Years – 10 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to determine if 8-week dietary treatment with the omega-3 fatty acid docosahexaenoic acid (DHA) improves attention performance and associated cortical activity and metabolism in 8 - 10 year old males that were not breast-fed during infancy.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTdocosahexaenoic acidDHA 400 mg/day (200mg twice daily), vs DHA 1200 mg/day (400 mg three times daily), vs placebo; 1:1:1 ratio

Timeline

Start date
2006-01-01
Primary completion
2008-01-01
Completion
2008-01-01
First posted
2008-04-21
Last updated
2013-05-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00662142. Inclusion in this directory is not an endorsement.

Effect of 8-Week Dietary DHA Supplementation on Cerebral Blood Flow and Metabolic Function (NCT00662142) · Clinical Trials Directory